April 23, 2007 2:00 PM
- Text
New Drug May Treat Muscular Dystrophy
- Adele's Grammy Comeback After Vocal Cord Surgery
- Treating Sleep Apnea in Kids Improves Behavior, Quality of Life
- Chemo May Not Harm Unborn Baby
- C-Sections Not Always Best for Small Babies
- CDC: Doctors Increasingly Prescribe Exercise
- Osteoporosis Medication Linked to Unusual Thigh Fractures
- More from WebMD »
generic DNA genetics chromosome helix gene genes genetic (iStockphoto)
(WebMD)
An experimental drug called PTC124 may override a gene glitch seen in Duchenne muscular dystrophy and various other genetic disorders.
Duchenne muscular dystrophy is one of nine major forms of muscular dystrophy. It's the most common type of muscular dystrophy in children and affects males. In Duchenne muscular dystrophy, the muscles decrease in size and grow weaker over time yet may appear larger. Disease progression varies, but many patients need a wheelchair by the time they're 12 years old.
The new drug, called PTC124, isn't available yet, but clinical trials are currently under way.
Today, researchers posted the results from lab tests in mice with a genetic glitch like one seen in a large group of genetic disorders, including Duchenne muscular dystrophy. The gene glitch hampers the production of dystrophin, a protein needed for muscle development. PTC124 is designed to override that gene glitch, putting dystrophin production back on track.
In lab tests, mice with muscular dystrophy (MD) got PTC124 orally and/or by injection for two to eight weeks.
"Enough dystrophin accumulated in the muscles of the MD mice so that we could no longer find defects in the muscle when we examined them," researcher H. Lee Sweeney, PhD, says in a news release. Sweeney chairs the University of Pennsylvania's physiology department.
"For all intents and purposes, the disease was corrected by treatment with PTC124" in the mice, Sweeney says.
If PTC124 succeeds in human tests, it may help treat Duchenne muscular dystrophy and similar genetic disorders, note the researchers, who included scientists from PTC Therapeutics, the company that makes PTC124. The study appears in the advance online edition of Nature.
By Miranda Hitti
Reviewed by Louise Chang, M.D.
©2007 WebMD, Inc. All rights reserved
Duchenne muscular dystrophy is one of nine major forms of muscular dystrophy. It's the most common type of muscular dystrophy in children and affects males. In Duchenne muscular dystrophy, the muscles decrease in size and grow weaker over time yet may appear larger. Disease progression varies, but many patients need a wheelchair by the time they're 12 years old.
The new drug, called PTC124, isn't available yet, but clinical trials are currently under way.
Today, researchers posted the results from lab tests in mice with a genetic glitch like one seen in a large group of genetic disorders, including Duchenne muscular dystrophy. The gene glitch hampers the production of dystrophin, a protein needed for muscle development. PTC124 is designed to override that gene glitch, putting dystrophin production back on track.
In lab tests, mice with muscular dystrophy (MD) got PTC124 orally and/or by injection for two to eight weeks.
"Enough dystrophin accumulated in the muscles of the MD mice so that we could no longer find defects in the muscle when we examined them," researcher H. Lee Sweeney, PhD, says in a news release. Sweeney chairs the University of Pennsylvania's physiology department.
"For all intents and purposes, the disease was corrected by treatment with PTC124" in the mice, Sweeney says.
If PTC124 succeeds in human tests, it may help treat Duchenne muscular dystrophy and similar genetic disorders, note the researchers, who included scientists from PTC Therapeutics, the company that makes PTC124. The study appears in the advance online edition of Nature.
By Miranda Hitti
Reviewed by Louise Chang, M.D.
©2007 WebMD, Inc. All rights reserved
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- Norovirus outbreak hits Rider University in N.J
- Chinese mom gives birth to 15-pound baby
- Marijuana-smoking motorists twice as likely to crash
- Electric shocks to brain may boost memory: Study
- America's sodium problem: Not from salty snacks?
- America's pets also have an obesity epidemic
- Caffeine inhalers - the next club drug?
- Measles patient at Super Bowl prompts health alert
- Skin cancer self-exam: What to look for (PHOTOS)
- 4.5 million Americans over 50 have artificial knees
- Things You Didn't Know About Your Penis
- PICTURES: 15 Shocking Sexual Fetishes
- Drinking soda raises risk for asthma, COPD: Study
- Let's Move! campaign turns 2 today: Is it working?
- Woman spotlights uterus didelphys on talk show
- Dr. Liar? Study finds dishonest docs common
Latest CBS News Headlines
on Facebook
on CBS News
- Wash. moves step closer to legalizing gay marriage
- Air Force trains flight attendants for VIP trips
- Item in Powell unit tests positive for blood
- Video: Man tries to carry girl away at Ga. Walmart
on Facebook
- Adele sings a cappella for Anderson Cooper
- Josh Powell had "incestuous" images on his home computer, authorities say
on CBS News
